Literature DB >> 1775401

Pulmonary vascular changes in bronchopulmonary dysplasia: a clinicopathologic correlation in short- and long-term survivors.

M Gorenflo1, M Vogel, M Obladen.   

Abstract

Pulmonary vascular findings in infants with bronchopulmonary dysplasia (BPD) are inconsistent. We compared five infants who fulfilled histologic criteria of BPD (group I; survival up to 1 month) with five controls who died of severe neonatal infection without having been ventilated. Nine infants who survived up to 7 months also fulfilled clinical criteria of BPD (group II). These were compared with three term infants who died of nonpulmonary causes. Lung slices were examined qualitatively and by quantitative histomorphometry. The influence of oxygen concentration and positive pressure ventilation on arterial density was studied. Arterial concentration in group I [2.43 (0.63) vessels/mm2, mean +/- SD] increased significantly compared with the controls [1.64 (0.49) vessels/mm2, mean +/- SD]. Most infants in group II who had cor pulmonale at autopsy had decreased arterial density when compared with normal term infants. Postmortem pulmonary angiography was also consistent with this finding. Total oxygen dose was the factor with the greatest influence on reduced arterial density. Relative wall thickness of vessels less than 75 microns in diameter was not significantly reduced in group I (p greater than .05). Infants from group II with cor pulmonale had an increased wall thickness compared with their controls. The proportion of fully muscularized arteries less than 100 microns in diameter was reduced in group I but increased in group II. We conclude that the reduction of cross-sectional perfusion area and abnormal muscularization of more peripheral vessels are important in the pathogenesis of pulmonary hypertension in infants with BPD.

Entities:  

Mesh:

Year:  1991        PMID: 1775401     DOI: 10.3109/15513819109065482

Source DB:  PubMed          Journal:  Pediatr Pathol        ISSN: 0277-0938


  11 in total

1.  Prospective analysis of pulmonary hypertension in extremely low birth weight infants.

Authors:  Ramachandra Bhat; Ariel A Salas; Chris Foster; Waldemar A Carlo; Namasivayam Ambalavanan
Journal:  Pediatrics       Date:  2012-02-06       Impact factor: 7.124

Review 2.  The Robyn Barst Memorial Lecture: Differences between the fetal, newborn, and adult pulmonary circulations: relevance for age-specific therapies (2013 Grover Conference series).

Authors:  Steven H Abman; Christopher Baker; Jason Gien; Peter Mourani; Csaba Galambos
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

3.  Intrauterine growth restriction decreases NF-κB signaling in fetal pulmonary artery endothelial cells of fetal sheep.

Authors:  R Blair Dodson; Kyle N Powers; Jason Gien; Paul J Rozance; Gregory Seedorf; David Astling; Kenneth Jones; Timothy M Crombleholme; Steven H Abman; Cristina M Alvira
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-05-03       Impact factor: 5.464

4.  Hypoxic ventilatory defence in very preterm infants: attenuation after long term oxygen treatment.

Authors:  M Katz-Salamon; H Lagercrantz
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-03       Impact factor: 5.747

Review 5.  The pulmonary circulation in neonatal respiratory failure.

Authors:  Satyan Lakshminrusimha
Journal:  Clin Perinatol       Date:  2012-09       Impact factor: 3.430

Review 6.  Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia.

Authors:  Christopher D Baker; Steven H Abman; Peter M Mourani
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-03-01       Impact factor: 1.349

Review 7.  Aberrant Pulmonary Vascular Growth and Remodeling in Bronchopulmonary Dysplasia.

Authors:  Cristina M Alvira
Journal:  Front Med (Lausanne)       Date:  2016-05-20

8.  Altered vasoreactivity in neonatal rats with pulmonary hypertension associated with bronchopulmonary dysplasia: Implication of both eNOS phosphorylation and calcium signaling.

Authors:  Eric Dumas de la Roque; Gwladys Smeralda; Jean-François Quignard; Véronique Freund-Michel; Arnaud Courtois; Roger Marthan; Bernard Muller; Christelle Guibert; Mathilde Dubois
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

9.  Soluble Klotho, a biomarker and therapeutic strategy to reduce bronchopulmonary dysplasia and pulmonary hypertension in preterm infants.

Authors:  Sunil Batlahally; Andrew Franklin; Andreas Damianos; Jian Huang; Pingping Chen; Mayank Sharma; Joanne Duara; Divya Keerthy; Ronald Zambrano; Lina A Shehadeh; Eliana C Martinez; Marissa J DeFreitas; Shathiyah Kulandavelu; Carolyn L Abitbol; Michael Freundlich; Rosemeire M Kanashiro-Takeuchi; Augusto Schmidt; Merline Benny; Shu Wu; Karen K Mestan; Karen C Young
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379

10.  Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.

Authors:  Devashis Mukherjee; Girija G Konduri
Journal:  Compr Physiol       Date:  2021-06-30       Impact factor: 8.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.